Deepika Gollapudi

Also affiliated with National Institute of Allergy and Infectious Diseases

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial”.

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00098-9

N/A

2.5DataRank · unranked

67 citations

Kaitlyn M. Morabito, Emily Phung, Michelle C. Crank, Pamela Costner, LaSonji A. Holman +74 more

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Science Translational Medicine(2023)10.1126/scitranslmed.ade4790

N/A

1.9DataRank · unranked

96 citations

Amelia R. Hofstetter, Katherine V. Houser, Seemal F. Awan, Grace Chen, Maria Claudia Burgos Florez +95 more

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00052-4

N/A

1.1DataRank · unranked

39 citations

Srilatha Edupuganti, Grace Chen, Myra Happe, Larisa Strom, Alicia T. Widge +67 more

Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development

Biotechnology Progress(2022)10.1002/btpr.3296

N/A

0DataRank · unranked

2 citations

Erwin Rosales‐Zavala, Vera B. Ivleva, Yanhong Yang, Yile Li, Sarah O’Connell +8 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Research Square(2022)10.21203/rs.3.rs-1534769/v1

N/A

0DataRank · unranked

0 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Quantification of prefusion conformation for HIV vaccine using size-exclusion chromatography

Journal of Chromatography B(2022)10.1016/j.jchromb.2022.123296

N/A

0DataRank · unranked

0 citations

William R. Shadrick, Yanhong Yang, Daniel B. Gowetski, Jason G. Gall, Q. Paula Lei +1 more

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

Scientific Reports(2020)10.1038/s41598-020-59711-y

N/A

0DataRank · unranked

57 citations

Wing‐Pui Kong, Gwo‐Yu Chuang, Mridul Ghosh, Krishana Gulla, Sijy O’Dell +69 more

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

mAbs(2023)10.1080/19420862.2023.2165390

N/A

0DataRank · unranked

14 citations

Jason Gorman, Young Do Kwon, Amarendra Pegu, Cara W. Chao, Tracy Liu +23 more

Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C

Journal of the American Society for Mass Spectrometry(2021)10.1021/jasms.1c00075

N/A

0DataRank · unranked

1 citations

Nicole A. Schneck, Taryn J. Cozine, Vera B. Ivleva, Daniel Ragheb, Deepika Gollapudi +5 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Scientific Reports(2022)10.1038/s41598-022-22435-2

N/A

0DataRank · unranked

14 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more